On this page
Overview
Product & regulatory status
Prescription androgen with historical FDA records; those records do not establish current authorization or availability of a particular propionate product.
Active hormone release
Tracer measurements show propionate supplying active testosterone after leaving the administered depot. [1]
What the evidence shows
What the propionate study measured
A 1986 isotope-tracer study in normal men measured movement of propionate from an intramuscular preparation into blood and its conversion to testosterone. It established pharmacokinetic behavior, not improvements in fatigue, fertility or long-term health. [1]
Broader testosterone evidence has limits
TRAVERSE found testosterone gel noninferior to placebo for major cardiovascular events in selected men with hypogonadism and elevated cardiovascular risk. It did not test propionate, performance enhancement or every potential adverse outcome. [2]
What remains unknown
Claims that propionate uniquely avoids estrogen-related effects or is universally easier to control are unestablished. Current product identity needs separate verification.
Safety
Class-wide blood-pressure concern
FDA’s 2025 action requires blood-pressure warnings across testosterone products; changing the ester does not eliminate the need to assess cardiovascular risk. [4]
Reproductive feedback
Exogenous testosterone can suppress pituitary reproductive signalling and sperm production. This is an androgen effect, not evidence that one ester preserves fertility. [5]
Historical is not current
The FDA archive concerns historical propionate products. A current vial should be assessed on its own label and provenance. [3]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [6]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [7]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Does the ester determine how I will feel?
It describes delivery chemistry. The cited studies do not provide an individual mood, energy or symptom-response forecast.
What needs verification on the prescription?
The exact manufacturer or compounder, active ingredient, authorized product status and route—not just the word testosterone.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Fujioka et al.: testosterone propionate pharmacokineticsJournal of Clinical Endocrinology and Metabolism, 1986; isotope-tracer pharmacokinetics in normal men.
- Lincoff et al.: TRAVERSENew England Journal of Medicine, 2023; 5,246 men with hypogonadism and cardiovascular disease or elevated risk; transdermal gel trial.
- FDA historical testosterone-propionate recordHistorical FDA regulatory material; not a current marketed-product label or evidence of current availability.
- FDA: testosterone labeling changesFebruary 28, 2025: cardiovascular boxed-warning changes and class-wide blood-pressure warning after TRAVERSE and ambulatory monitoring studies.
- Testosterone enanthate multidose-vial labelUS prescribing information · revised June 2025 · DailyMed updated May 2026
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.